Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07ELT
|
|||
| Former ID |
DIB015177
|
|||
| Drug Name |
NOX-700
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Phase 1 | [1] | |
| Company |
Medinox
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Nitric oxide elimination (NOE) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Medinox. | |||
| REF 2 | Inhibition of nitrosylation, nitration, lymphocyte proliferation, and gene expression in acute and delayed cardiac allograft rejection by an orally active dithiocarbamate. J Cardiovasc Pharmacol. 2004 Apr;43(4):522-30. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.